CN104042921A - Traditional Chinese medicine composition for treating leucoderma - Google Patents
Traditional Chinese medicine composition for treating leucoderma Download PDFInfo
- Publication number
- CN104042921A CN104042921A CN201410303672.XA CN201410303672A CN104042921A CN 104042921 A CN104042921 A CN 104042921A CN 201410303672 A CN201410303672 A CN 201410303672A CN 104042921 A CN104042921 A CN 104042921A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- cortex
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating leucoderma. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 16-22 parts of radix arnebiae, 16-22 parts of dalbergia odorifera, 10-14 parts of rhizoma bletillae, 10-14 parts of cortex dictamni, 8-12 parts of flos abelmoschus manihot, 8-12 parts of schizonepeta, 6-10 parts of cortex illicii difengpi, 6-10 parts of entada phaseoloides, 5-10 parts of centella asiatica and 5-10 parts of poria peel. The traditional Chinese medicine composition disclosed by the invention is capable of effectively relieving the condition of a leucoderma patient and fundamentally treating leucoderma, short in treatment course, high in recovery rate, free of recurrence, safe and free of toxic or side effect.
Description
Technical field
The present invention relates to one and treat leukodermic Chinese medicine composition, belong to the field of Chinese medicines.
Background technology
Vitiligo is the dermatosis that a kind of limitation melanin runs off, patient is generally without any subjective symptoms, only on skin, occur that size shape differs, number is indefinite, clearly white macula of boundary, white macula can occur in any position, locates also to make the hair at this place bleach if occur in scalp, eyebrow, eyelashes etc.The leukodermic cause of disease is also not fully aware of, has been commonly considered as due to tegumentary chromatophore shortage Inhibition of Tyrosinase Activity skin pigment metabolism, and tegumentary chromatophore can not be produced due to melanin.The traditional Chinese medical science thinks that vitiligo is because rheumatism is strongly fragrant due to fur, qi-blood disharmony, the skin losing its nutrition.Generally take effect slowlyer but treat at present leukodermic Chinese medicine preparation, treatment cycle is longer.
Summary of the invention
The object of this invention is to provide one and treat leukodermic Chinese medicine composition, meet the viewpoint of differentiation of tcm, therapeutic effect is good, and without recurrence, toxic and side effects is little.
For achieving the above object, the present invention adopts following technical proposals:
One is treated leukodermic Chinese medicine composition, is to be made up of the raw material of following weight parts:
Radix Arnebiae (Radix Lithospermi) 16-22 part, Lignum Dalbergiae Odoriferae 16-22 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-14 part, Cortex Dictamni 10-14 part, Flos abelmoschi manihot 8-12 part, Herba Schizonepetae 8-12 part, Cortex Illicii 6-10 Fen ， Semen Entadae 6-10 part, Herba Centellae 5-10 part, Cortex Sclerotii Poriae 5-10 part.
The leukodermic Chinese medicine composition of this treatment, preferred medicament composing prescription is:
20 parts of Radix Arnebiae (Radix Lithospermi)s, 18 parts of Lignum Dalbergiae Odoriferaes, 12 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 12 parts of Cortex Dictamni, 10 parts of Flos abelmoschi manihots, 10 parts of Herba Schizonepetae, 8 parts of Cortex Illicii 8 Fen ， Semen Entadae, 8 parts of Herba Centellaes, 8 parts of Cortex Sclerotii Poriae.Each taste crude drug in prescription is the kind that " Chinese Pharmacopoeia " (version in 2010) recorded, and its quality all meets the regulation under each kind item.
Leukodermic pathogenesis is: in ailment said due to cold or exposure, attack, cause mechanism of qi operation not smooth, the stagnation of QI is blood stasis, and blood stasis is visceral dysfunction, blood is not supported skin, cause skin cervical carcinoma with cachexia, treat taking invigorating qi and benefiting blood, promoting blood circulation by removing wind, eliminating dampness and dredging channels as the rule for the treatment of, in medicament composing prescription of the present invention, each drug component is through dialectical compatibility, in drug action, assistant helps mutually, plays altogether the effect that consolidates mark, righting evil removing, fundamentally vitiligo is realized to treating both the principal and secondary aspects of a disease.
Using method: decocting method, for oral administration, 1 dose of every day, decoct twice, merge twice medicinal liquid and be equally divided into two parts, sooner or later divide 2
Inferior decoction being taken warmly.1 month 1 course for the treatment of, treat two courses for the treatment of.
Beneficial effect of the present invention:
Chinese medicine composition of the present invention can effectively be alleviated the state of an illness of patients with vitiligo, and treatment short treating period, can fundamentally treat vitiligo, and cure rate is high, without recurrence, safe without toxic side effect.
Detailed description of the invention
Below by instantiation, the present invention will be further elaborated, should be noted that following explanation is only in order to explain the present invention, does not limit its content.
Embodiment 1
One is treated leukodermic Chinese medicine composition, is to be made up of the raw material of following weight parts:
20 grams of Radix Arnebiae (Radix Lithospermi)s, 18 grams of Lignum Dalbergiae Odoriferaes, 12 grams of Pseudobulbus Bletillae (Rhizoma Bletillae), 12 grams of Cortex Dictamni, 10 grams of Flos abelmoschi manihots, 10 grams of Herba Schizonepetae, 8 grams of Cortex Illicii 8 Ke ， Semen Entadae, 8 grams of Herba Centellaes, 8 grams of Cortex Sclerotii Poriae.
Using method: decocting method, for oral administration, 1 dose of every day, decoct twice, merge twice medicinal liquid and be equally divided into two parts, sooner or later divide 2
Inferior decoction being taken warmly.1 month 1 course for the treatment of, treat two courses for the treatment of.
Embodiment 2
One is treated leukodermic Chinese medicine composition, is to be made up of the raw material of following weight parts:
16 grams of Radix Arnebiae (Radix Lithospermi)s, 22 grams of Lignum Dalbergiae Odoriferaes, 10 grams of Pseudobulbus Bletillae (Rhizoma Bletillae); 14 grams of Cortex Dictamni, 8 grams of Flos abelmoschi manihots; 12 grams of Herba Schizonepetae; 10 grams of Cortex Illicii 6 Ke ， Semen Entadae, 5 grams of Herba Centellaes, 10 grams of Cortex Sclerotii Poriae.
Using method is same embodiment 1.
Embodiment 3
One is treated leukodermic Chinese medicine composition, is to be made up of the raw material of following weight parts:
22 grams of Radix Arnebiae (Radix Lithospermi)s, 16 grams of Lignum Dalbergiae Odoriferaes, 14 grams of Pseudobulbus Bletillae (Rhizoma Bletillae), 10 grams of Cortex Dictamni, 12 grams of Flos abelmoschi manihots, 8 grams of Herba Schizonepetae, 6 grams of Cortex Illicii 10 Ke ， Semen Entadae, 10 grams of Herba Centellaes, 5 grams of Cortex Sclerotii Poriae.
Using method is with embodiment 1.
Clinical data:
(1) case selection: select clinical observation case 68 routine patients to carry out clinical observation treatment, wherein male's case 34 examples, women's case 34 examples, age 16-60 year.
(2) case diagnosis and criterion of therapeutical effect:
Cure: local white macula disappears completely, and whole body can be looked into without positive sign.
Effective: white macula area obviously dwindles, occur without new white macula.
Invalid: symptom is without improvement.
(3) Therapeutic Method: get the medicament composing prescription of the embodiment of the present invention 1, decocting method, for oral administration, 1 dose of every day, decoct twice, merge twice medicinal liquid and be equally divided into two parts, sooner or later point 2 decoction being taken warmly.1 month 1 course for the treatment of, treat two courses for the treatment of.
(4) therapeutic effect:
Treat 68 examples, clinical cure 51 examples, effective 12 examples, invalid 5 examples, total effective rate is 92.6%.
Claims (2)
1. the leukodermic Chinese medicine composition for the treatment of, is characterized in that, is to be made up of the raw material of following weight parts:
Radix Arnebiae (Radix Lithospermi) 16-22 part, Lignum Dalbergiae Odoriferae 16-22 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-14 part, Cortex Dictamni 10-14 part, Flos abelmoschi manihot 8-12 part, Herba Schizonepetae 8-12 part, Cortex Illicii 6-10 Fen ， Semen Entadae 6-10 part, Herba Centellae 5-10 part, Cortex Sclerotii Poriae 5-10 part.
2. one as claimed in claim 1 is treated leukodermic Chinese medicine composition, it is characterized in that, be to be made up of the raw material of following weight parts: 20 parts of Radix Arnebiae (Radix Lithospermi)s, 18 parts of Lignum Dalbergiae Odoriferaes, 12 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 12 parts of Cortex Dictamni, 10 parts of Flos abelmoschi manihots, 10 parts of Herba Schizonepetae, 8 parts of 8 parts of Semen Entadae of Cortex Illicii, 8 parts of Herba Centellaes, 8 parts of Cortex Sclerotii Poriae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410303672.XA CN104042921A (en) | 2014-06-30 | 2014-06-30 | Traditional Chinese medicine composition for treating leucoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410303672.XA CN104042921A (en) | 2014-06-30 | 2014-06-30 | Traditional Chinese medicine composition for treating leucoderma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104042921A true CN104042921A (en) | 2014-09-17 |
Family
ID=51496644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410303672.XA Pending CN104042921A (en) | 2014-06-30 | 2014-06-30 | Traditional Chinese medicine composition for treating leucoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104042921A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105902724A (en) * | 2016-05-28 | 2016-08-31 | 蒋保珍 | Chinese medicinal composition for treatment of wind-cold-damp type vitiligo |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103623020A (en) * | 2013-12-01 | 2014-03-12 | 卡玛力亚·努尔加吾 | Traditional Kazakh pharmaceutical composition for treating leucoderma and preparation method of traditional Kazakh pharmaceutical composition |
-
2014
- 2014-06-30 CN CN201410303672.XA patent/CN104042921A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103623020A (en) * | 2013-12-01 | 2014-03-12 | 卡玛力亚·努尔加吾 | Traditional Kazakh pharmaceutical composition for treating leucoderma and preparation method of traditional Kazakh pharmaceutical composition |
Non-Patent Citations (3)
| Title |
|---|
| 刘晓玉等: "当代8位名老中医论治白癜风经验荟萃", 《中国中西医结合皮肤性病学杂志》 * |
| 宋业强等: "53味治疗白癜风中药水提物对蘑菇酪氨酸酶活性的影响", 《中华中医药杂志》 * |
| 谢韶琼等: "白癜风的中医治疗及研究进展", 《中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105902724A (en) * | 2016-05-28 | 2016-08-31 | 蒋保珍 | Chinese medicinal composition for treatment of wind-cold-damp type vitiligo |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103386008A (en) | Chinese medicine composition for treating endocrine dyscrasia | |
| CN104107395A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN102698092A (en) | Traditional Chinese medicine composition for treating liver-Yang hyperactivity-type hypertension | |
| CN102274385B (en) | Medicament for treating nasosinusitis and preparation method thereof | |
| CN102698058B (en) | Health care extract for adjusting sub-healthy state of human body | |
| CN104189759A (en) | Traditional Chinese medicine composition for treating cholelithiasis | |
| CN103041145B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN105616937A (en) | Traditional Chinese medicine for treating diabetes | |
| CN104042921A (en) | Traditional Chinese medicine composition for treating leucoderma | |
| CN103933475B (en) | A kind of pharmaceutical composition treating mammary gland fibroma and its production and use | |
| CN105687347A (en) | Medicine for treating insomnia of old people | |
| CN102512560A (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
| CN104940673A (en) | Traditional Chinese medicinal lotion for treating chemotherapy-induced peripheral neuropathy and nursing method | |
| CN105288122A (en) | Drug for treating diabetes mellitus | |
| CN104127797B (en) | It is a kind of to treat Chinese medicine preparation of aphasia and preparation method thereof after craniocerebral trauma | |
| CN103768214B (en) | A kind of Chinese medicine composition for the treatment of kidney yang deficiency syndrome rhinitis | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN102580004B (en) | Chinese medicinal composition for treating male erectile dysfunction | |
| CN102772620B (en) | Medicine for inhibiting recurrence of cancer after surgery | |
| CN103948764A (en) | Traditional Chinese medicine for treating edema during menstruation | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN105687433A (en) | Traditional Chinese medicinal preparation for treating skin psoriasis | |
| CN104689253A (en) | Traditional Chinese medicine composition for treating gallbladder removal syndromes | |
| CN104013940A (en) | Traditional Chinese medicine for fumigation foot bath to treat insomnia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140917 |